This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will evaluate the feasibility, acceptability, and preliminary efficacy of the "CHAMPION" intervention package for increasing PrEP (pre-exposure prophylaxis) adherence among HIV-negative methamphetamine-using men who have sex with men (MSM). The $404,616 award to the University of California, San Diego will fund a 6-month randomized...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development and assessment of a behavioral economic intervention to improve HIV-related behaviors among sexual minority men (SMM). The $264,091 award, effective September 15, 2024, aims to refine and evaluate the feasibility and acceptability of an Episodic Future Thinking (EFT) intervention delivered via smartphone to address delayed...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to develop a multi-level integrated strategy to optimize adherence to HIV pre-exposure prophylaxis (PrEP) among Black men who have sex with men (MSM). The $2,127,639 grant will fund the combination of two evidence-based interventions - the "Many Men, Many Voices" (3MV) program and the Client-Centered Care Coordination (C4)...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under CFDA 93.242 Mental Health Research Grants is providing $664,382 to the University of Massachusetts Medical School to develop and pilot a mobile health (mHealth) intervention to overcome stigma and promote use of pre-exposure prophylaxis (PrEP) among Thai young transgender women (TGW), a population at high risk of HIV. The award will fund the adaptation of the Healthy Choices (HC) intervention for mHealth...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $239,148 to the Regents of the University of Minnesota to develop and pilot a telehealth intervention delivered through syringe service programs (SSPs) to improve uptake and retention of pre-exposure prophylaxis (PrEP) and medication for opioid use disorder (MOUD) among people who inject drugs (PWID). The 3-year project (9/15/2024 - 7/31/2027) will...
This federal Project Grant award, titled "OPTIMIZING LONG-ACTING INJECTABLE PREP STRATEGIES FOR SEXUAL MINORITY MEN WHO USE METHAMPHETAMINE", is funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $1,260,957 award, spanning from September 30, 2024 to March 21, 2025, aims to identify preferences and priorities for using long-acting injectable pre-exposure prophylaxis (LAI PrEP) among sexual minority men who use...
This $616,742 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to characterize geographic mobility patterns and determine the impact on PrEP and HIV care outcomes among Latino gay, bisexual, and other men who have sex with men (GBMSM) in New York City. The research will involve qualitative in-depth interviews and mobility mapping with 80 Latino GBMSM participants, including those living with and without...
This $364,832 Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund the delivery and evaluation of an enhanced care intervention called "HIV Prevention Plus Care (HP+ Care)" for young men who have sex with men (YMSM) starting pre-exposure prophylaxis (PrEP) in two clinics. The HP+ Care intervention will include motivational interviewing and personalized health education to promote retention in...
The National Institute on Minority Health and Health Disparities (NIMHD) awarded a $338,544 Project Grant (CFDA 93.307 - Minority Health and Health Disparities Research) to The Johns Hopkins University to develop and test a trauma-informed mHealth and peer support intervention called "BOUNCE." This intervention aims to promote PrEP (Pre-Exposure Prophylaxis) uptake among gay, bisexual, and other men who have sex with men (MSM) in the United States, a population disproportionately...
The National Institute on Drug Abuse (NIDA) awarded a $1,334,540 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The University of Kentucky Research Foundation. The grant funds a 5-year project to optimize the delivery of pre-exposure prophylaxis (PrEP) care for people who inject drugs (PWID) in rural Kentucky. The project will deploy adaptive intervention strategies, including peer-led case management and mobile outreach, across three rural syringe service...